In a study, partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality. Although novel targeted and ...

Nephron-sparing management is one strategy to reduce risks, according to investigators. Older age is significantly associated with greater kidney function decline after radical nephrectomy in patients ...

Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi). This is an ASCO Meeting Abstract from the 2023 ASCO ...

Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

Stage 2 ccRCC is localized, with tumors larger than 7 cm but no lymph node or distant metastasis involvement. Diagnosis involves imaging, laboratory tests, and occasionally biopsy, with surgery as the ...

First preliminary results of artificial intelligence-generated, explainable treatment recommendations for renal cell cancer based on multidisciplinary cancer conferences. Multivariate adjusted ...

Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children's Research Hospital scientists demonstrated that in bilateral Wilms tumor ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular ...